drugset / Trial / NCT04738357

A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia

NCT04738357

Phase 3 Completed 276 enrolled Haisco Pharmaceutical Group Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a multi-center, randomized, double-blind, placebo-controlled study. A total of 276 subjects undergoing elective laparoscopic surgery under general anesthesia are planned to be enrolled and randomized into 2 groups, i.e., the HSK21542 group (138 subjects) and the placebo group (138 subjects).

Timeline

Start
2021-03-24
Primary completion
2021-07-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK21542 Peptide 1 ug/kg Intravenous

Indications

No indication recorded.